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Macrophages and monocytes produce large amounts of lysozyme (LZM), most 
of which is secreted (1). Granulocytes also contain but do not normally secrete 
the enzyme (2). Elevated levels of LZM in urine and serum are a  diagnostic 
indicator for acute monocytic leukemia and acute myelomonocytic  leukemia (3). 
We report here an unusual human cell line, U-937, derived from a patient with 
histiocytic lymphoma  1  which synthesizes LZM. The cell line lacks immunoglob- 
ulin and Epstein-Barr virus (EBV) genome, but bears receptors for immuno- 
globulin and complement (C).  For comparison we describe LZM synthesis by 
several murine histiocytic lymphoma cell lines with macrophage properties of 
antibody-dependent phagocytosis and exocytolysis (4, 5), and by other lympho- 
mas in culture including a myelomonocytic  leukemia resembling the progenitor 
of macrophages and granulocytes (6). 
Materials and Methods 
Human Cell Lines.  The U-937 line was established from the pleural effusion of a patient with 
a  generalized, diffuse histiocytic lymphoma as detailed elsewhere. 1 The cells bear receptors for 
immunoglobulin (31% EA) and C (11% EAC), phagocytose latex beads and formalin-fixed Staphy- 
lococcus aureus but not zymosan, and do not have detectable EBV genome or surface (fluorescence) 
or intracellular (gel diffusion) immunoglobulin. The line bears no resemblance to other EBV- 
positive or negative T- and B-lymphoid lines (7). Growth of U-937 is dependent on feeder layers or 
conditioned medium of human glia cells (8).  Maximum cell density is 2  x  10  ~ ml. Other human 
hematopoietic cell lines studied include B-lymphoblastoid cell lines of non-neoplastic origin and 
EBV-positive and negative neoplastic leukemia, lymphoma, and myeloma cell lines, according to 
the classification by Nilsson and Pont~n (7). These lines were maintained in nonstirred suspension 
cultures fed twice a  week by medium  F10 or RPMI  1640  (Grand Island Biological Co.,  Grand 
Island, N. Y.) supplemented by 10% newborn calf serum and antibiotics (100 IU/ml penicillin, 50 
~g/ml streptomycin, and 1.25 ~g/ml amphotericin B). All cultures were incubated at 37°C in a 5% 
CO2-air atmosphere. 
Murine Cell Lines.  Cell lines were adapted from ascites or solid forms of lymphomas without 
the use of reducing agents, in some cases by repeated cycles of culture and mouse passages. Cell 
line PU5-1.8 was derived from lymphoma PU5-1 by transferring a  solid tumor at passage 35 into 
mice intraperitoneally, transferring ascites cells three times, and adapting the ascites cells from 
passage 39 to culture. Another cell line, PU5-1/1, was derived from a tumor at animal passage 44, 
maintained in culture  1 mo,  and then passaged once as ascites.  Cell lines grow in RPMI  1640 
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medium or Dulbecco's modified Eagle's medium containing 10% fetal calf serum in 10-13% CO2 
incubators using plastic Petri dishes  (9), except for J774 and PC334 which were grown in plastic 
tissue culture dishes.  Doubling times range from 10 to 24 h, except for PC334 which was slow 
growing. PC334 is strongly adherent (subcultured  by trypsin-EDTA); PU5-1.8, J774, P388 D1, and 
WEHI-3 are loosely adherent; and the other lines nonadherent. 
LZM.  When cultures reached approximately 106 cells/ml, but still in exponential  growth with 
viability exceeding 85%, cells were harvested by centrifugation (1 rain at 1,000 g). The cell pellet 
was lysed by 0.3 ml of 1% Nonidet P40 (Shell Chemical Corp., New York) in saline per 107 cells for 
5 min at 4°C. The extract and culture medium were centrifuged  10 rain at 10,000 g. LZM was 
assayed in these supernates turbidimetrically (3) using egg-white LZM as a standard and results 
are stated in units of micrograms egg LZM. Cell lines U-937 and PC-334 do not reach a density of 
10e/ml, and their activity has been normalized to 10  e cells. Serum, urine, ascites,  and single cell 
suspensions from solid tumors were similarly assayed. Nonidet P40 did not affect the assay at the 
highest final concentrations  used (0.2%). 
Colony-Stimulating Factor (CSF).  CSF was assayed as previously described  (6). 
Results 
LZM Synthesis  by Human  Cell Lines.  Only  1  (U-937)  of the  18  hemato- 
poietic cell lines tested synthesized detectable amounts of LZM (Table I). When 
U-937  cultures  reach  105  cells/ml,  extracellular  medium  contains  0.5-0.8  ~g 
LZM/ml, while intracellular enzyme levels amount to 0.3-0.8 ~g/105 cells. Thus 
50 to 70% of the LZM synthesized appears to be secreted since there is negligible 
cell death under these conditions. 
LZM Synthesis  by  Murine  Cell Lines  and  Tumors.  Cell  lines  J774  and 
PC334 from well-differentiated histiocytic lymphomas synthesize large amounts 
of LZM (Table II), 80-90% of which is secreted.  Serum, urine,  ascites fluid and 
intracellular  content  of ascites,  and  solid  tumor  cells  of tumor-bearing  mice 
contain greatly elevated levels of LZM. Another cell line, P388 D1, with macro- 
phage properties (18) also produces similar amounts of LZM (not shown). 2 The 
WEHI-3 myelomonocytic leukemia line synthesizes moderate amounts of LZM, 
50-70% of which is secreted.  Mice bearing this tumor are also positive. 
A  spontaneous lymphoma PU5-1 with properties of B lymphocytes showed no 
LZM activity in tumors or in a  cell line PU5-1/1.  However, another line,  PU5- 
1.8, produces easily detectable LZM, and the enzyme is associated with ascites 
and solid tumors formed from the latter cell line.  An Abelson leukemia virus- 
induced  lymphoma cell  line,  RAW  8,  also  produces  LZM.  Hematopoietic cell 
lines  found  negative  for  LZM  include  Abelson  virus-induced  lymphoma  RS, 
myelomas,  T  lymphomas,  mastocytoma,  and  chemically  induced  P388  lym- 
phoma with lymphoid characteristics. 
Synthesis  of Colony-Stimulating  Factor (CSF)  by  Cell Lines.  CSF  is  re- 
quired  by bone  marrow  progenitor  cells  to  proliferate  into  granulocytes  and 
monocytes  in  vitro.  Serum  levels  of CSF  are  elevated  in  mice  carrying  the 
myelomonocytic leukemia  WEHI-3  (6).  The  cell line growing in culture  since 
January,  1974,  was therefore tested for CSF.  When  introduced  into  agar cul- 
tures at a  final concentration  of hl0  (optimal conditions),  WEHI-3 supernates 
stimulate the production of 100-150 colonies per 7.5  ×  104 mouse bone marrow 
cells. WEHI-3 CSF and normal mouse CSF are inactive with human progenitor 
cells. Neither human nor mouse CSF activity was detected in supernates of the 
other cell lines. 
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TABLE  I 
Lysozyme Associated with Human Cell Lines 
Positive cell line  Medium  Intracellular 
gg  /ml  ~g  /l O  6 
5-8  3-8 
Negative cell lines 
Histiocytic lymphoma 
U-937 (footnote 1) 
B lymphoblastoid  EBV +  Myeloma 
U-704 (i0)  266BL (8, i0) 
WIL-2 (II)  8226 (7, i0, ii) 
8866 (11)  T lymphoblastic  leukemia 
UM-37 (11)  MOLT  4 (7, 10) 
Burkitt's lymphoma EBV +  CCRF-CEM  (15,  16) 
RAJI (10,  11, 12)  CCRF-H-SB-2  (15,  16) 
DAUD1  (10,  11, 12)  CML 
RAMOS  (12)  K562 (17) 
Non-Burkitt's lymphoma EBV  Bone marrow, epitheloid 
U-698 (10,  13)  -  D98 (16) 
U-715 (10,  13)  -  Jlll (16) 
8-95 (I0,  14)  + 
Lower limit  of  LZM detection  was 0.2/~g/ml in  the extracellular  medium per I0'  cells  and 0.05/~gll0  s  cells  in lysates.  LZM 
was not  found in control  glial  cells  or culture supernates used  as  feeder layers  for  U-937 growth. Reference to  cell  lines  are 
given in parentheses. 
Discussion 
The group of histiocytic lymphomas comprises a  variety of histopathologic 
types making diagnosis and classification difficult. In the mouse, there are 
transplantable tumor models for:  (a)  the  well-differentiated histiocytic lym- 
phoma with properties of macrophages (4), and (b) the pleomorphic reticulum 
cell sarcomas occurring spontaneously in SJL mice, which in some respects 
resemble Hodgkin's disease by presenting a variety of cell types (21). The well- 
differentiated histiocytic lymphomas J774  and  PC334 exhibit high levels of 
phagocytosis (latex beads and zymosan), pinocytosis (neutral red), and anti- 
body-dependent  phagocytosis and exocytolysis  of erythrocytes (5) not found with 
spontaneous SJL tumors (unpublished observation). Similar macrophage-like 
properties have been described for cell lines P388 D1 (18) and 1C-21 (22). Tumor 
forms of the latter two lines are not available. 
We show here that high levels of lysozyme are found in mice bearing well- 
differentiated histiocytic lymphomas, as described by Riblet and Herzenberg 
(23), and that cell lines derived from these tumors maintain LZM synthesis in 
vitro. The culture macrophage line 1C-21 was previously shown to synthesize 
LZM (24). Some Abelson virus-induced neoplasms are thought to be of  immature 
myelomonocytic  origin (25), confirmed  by LZM synthesis in the RAW 8 cell line 
derived by infecting spleen cells in vitro (19). The relation of LZM-positive PU5- 
1.8 line to the lymphoma PU5-1 remains unclear, but it is not a contaminant of a 
different cell line since no other line exists with PU5-1.8 properties (9). 
Besides lysozyme synthesis, another characteristic of the histiocyte-monocyte 
series is the production of CSF (26). Only the LZM  + myelomonocytic  leukemia 
WEHI-3 was found to synthesize CSF. The CSF- LZM  + lines PUS-1.8 and RAW 
8 may represent an earlier form of this cell type unable to differentiate further. 
Rat myelogenous leukemia and chloroma cell lines have been reported posi- 
tive by histechemical staining for LZM (27). Of the human lines tested, only U- 
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TABLE  II 
Lysozyme Associated with Marine Tumors and Cell Lines 
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Cell  line 
~listiocytic  lymphoma 
J774 (4,  5) 
PC334 (R. Riblet) 
~belson  lymphoma 
RAW  8 (9, 11, 19) 
R8 (9, 19) 
~lyelomonocytic  leukemia 
WEHI-3 (6,  20) 
~pontaneous  lymphoma 
PU5-1/1 (11) 
PU5-1.8 (9, 11) 
~fyelomas 
MOPC-315, P3 (11) 
r lymphomas 
EIA, $49 (11) 
~lastocytoma 
P815 (11) 
Lymphoid  neoplasm 
Strain 
C* 
C x NZB 
C 
C×B 
C 
C 
C 
C 
B,C 
D 
Tumors 
Ascitic  Serum  Urine  Fluid 
#glml  pglral  :ag/ml 
5-200  200-700  40-1500 
ND  ND  45-150 
3-14  3-63  ND 
2-3  2-7  2-11 
10-17  16-300  50-200 
2-8  3-8  7-25 
8-15  50-500  120-280 
1-3  0.9  1-3 
ND  ND  ND 
ND  ND  1-3 
ND  ND 
Cell  cultures 
Cells  Medium  Cells 
~g/lO" 
0.04-0.22 
ND 
ND 
<0.007 
0.1-1.0 
<0.02 
0.3-0.7 
<0.02 
ND 
ND 
ND 
~/ml 
2-25 
10-100 
2-5 
<0.3 
0.1-0.8 
<0.1 
1-50 
<0.i 
<0.I 
<0.i 
<0.i 
~/10 e 
0.02-0.5 
ND 
0.1-0.5 
<0.007 
0.05-0.8 
<0.01 
0.2-10 
<0.001 
<0.001 
<0.001 
<0.01  P388 (9, 18)  D  ND 
* Strains  of  mice:  C, BALB/c; B, C57BL/6; D, DBA/2. 
leukemia line  synthesize LZM. These are the first  examples of  a human neo- 
plasm adapted to culture and positively  typed by a functional assay for the 
monocyte-granulocyte  cell  series.  Philadelphia chromosome has been described 
in the myeloid line K562 (17),  although the subline studied here lacks the 
karyotypic marker.  3  Three cell  lines  of Epstein and Kaplan (29)  from diffuse 
histiocytic  lymphoma patients resemble the original  tumor cells  morphologi- 
cally  and show staining  characteristics  compatible with a  histiocyte  origin.  LZM 
production was not studied. 
In view of the variety of aberrant behavior shown by many culture lines, 
further  studies  with the cell  lines  described  here are necessary to confirm their 
retention of myelocyte/monocyte-specific properties. The lines should aid in 
diagnosis and classification  of lymphomas,  analysis of mechanisms  of drug 
action and evaluation of new chemotherapeutic agents, and investigations  of 
tumor antigens a well  as of  the normal functions  of  the rnonocyte,  histiocyte, 
and granulocyte series  of  cells. 
Summary 
A human cell line established in culture from a histiocytic lymphoma patient 
synthesizes and secretes the monocyte-granulocyte specific enzyme lysozyme. 18 
other  human  cell  lines  with  characteristics  of T-lymphocyte,  B-lymphocyte, 
Burkitt's  lymphoma,  non-Burkitt's  lymphoma,  myeloma,  and  bone  marrow 
epithelial cells were not associated with lysozyme. 
Among  marine  cell  lines,  lysozyme  was  produced  by  (a)  three  histiocytic 
3 Klein,  E.,  H.  Ben  Bassat,  H.  Neumann,  P.  Ralph,  A.  Polliak,  and  F.  Vanky.  1976. 
Characterization of  the K562 cell  line derived from a chronic myeloid leukemia patient. Manu- 
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lymphoma or macrophage lines, which mediate antibody-dependent phagocyto- 
sis and cytolysis; (b) myelomonocytic leukemia line which also secretes myeloid 
colony-stimulating  factor;  and  (c)  a  spontaneous  lymphoma  and  an  Abelson 
leukemia  virus-induced  lymphoma.  Lysozyme-negative lines  include  another 
Abelson lymphoma, myelomas, T  lymphomas, and mastocytoma. 
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